The Scientist

» Big Pharma

Most Recent

image: Lazarus Drugs

Lazarus Drugs

By | February 1, 2015

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.  

1 Comment

image: Roche Buys Bioinformatics Firm

Roche Buys Bioinformatics Firm

By | December 22, 2014

The pharmaceutical giant will pay an undisclosed price to acquire Bina Technologies.

0 Comments

image: Merck Buys Cubist for $8.4B

Merck Buys Cubist for $8.4B

By | December 11, 2014

Hours after the pharmaceutical giant announced the acquisition, a federal judge invalidated key patents behind the antibiotic maker’s most lucrative product.

0 Comments

image: Taking Shots at Ebola

Taking Shots at Ebola

By | November 5, 2014

With an infusion of public and private resources and accelerated regulatory processes, a handful of companies are racing to develop a vaccine to curb the Ebola epidemic.

4 Comments

image: Roche Buys Biotech for $8.3B

Roche Buys Biotech for $8.3B

By | August 27, 2014

The pharma giant strikes a deal to acquire InterMune, a Brisbane, California-based biotech with only one product—a treatment for a fatal lung disease.

0 Comments

image: Roche Set to Buy RNAi Firm

Roche Set to Buy RNAi Firm

By | August 6, 2014

The Swiss pharmaceutical giant will reportedly pay $450 million for a Danish biotech company that develops drugs that silence microRNAs.

2 Comments

image: Novartis and Glaxo Agree to Big Deal

Novartis and Glaxo Agree to Big Deal

By | April 22, 2014

The pharmaceutical companies announce a suite of asset swaps that drove up share prices and will reshape both.

2 Comments

image: J&J to Share Trial Data

J&J to Share Trial Data

By | January 31, 2014

The pharmaceutical giant teams up with Yale University to make raw clinical data available to researchers.

0 Comments

image: UK Government Laments Tamiflu Secrets

UK Government Laments Tamiflu Secrets

By | January 6, 2014

A parliamentary committee says drugmakers have not disclosed enough data on the anti-influenza medicine.

0 Comments

image: Pharma Moves Toward Transparency

Pharma Moves Toward Transparency

By | July 29, 2013

The pharmaceutical industry has agreed to share data from clinical trials with researchers, patients, and the public.

0 Comments

Popular Now

  1. Gut Microbes Linked to Neurodegenerative Disease
  2. Opinion: WHO’s Silence on Cannabis
  3. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

  4. Image of the Day: Parting Ways
    Image of the Day Image of the Day: Parting Ways

    The Allen Institute for Cell Science releases the first public collection of human induced pluripotent stem cells that have been fluorescently tagged using CRISPR.

Rockland